917737
NanoFabTx™ materials screening kit
for synthesis of polymeric nanoparticles
Synonym(e):
Non-PEGylated drug delivery formulation, PCL, PLA, PLGA
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
UNSPSC-Code:
12161503
NACRES:
NA.23
Empfohlene Produkte
Beschreibung
Kit components :
PLGA-Nano (907782-500mg)
PLGA-Nano75 (916382-500mg)
PLA-Nano (910996-500mg)
PCL-Nano (916382-500mg)
Stabilizer - P (913448-10g)
Qualitätsniveau
Anwendung(en)
advanced drug delivery
Allgemeine Beschreibung
NanoFabTx™ formulation kits and lipid mixes enable users to encapsulate a wide variety of therapeutic drug molecules for targeted or extended drug delivery without the need for lengthy trial-and-error optimization. NanoFabTx™ kits provide an easy to use toolkit for encapsulating a variety of therapeutics in nanoparticles, microparticles, or liposomes. Drug encapsulated particles synthesized with the NanoFabTx™ kits are suitable for biomedical research applications such as oncology, immuno-oncology, gene delivery and vaccine delivery.
Anwendung
The NanoFabTx™ materials screening kit, for synthesis of polymeric nanoparticles, is a ready-to-use nanoformulation kit for the synthesis of nanoparticles for drug delivery. Poly(lactic-co-glycolic acid) (PLGA), poly(D,L-lactic acid) (PLA) and polycaprolactone (PCL) are biocompatible and biodegradable polymers that have been approved by the FDA for biomedical and pharmaceutical applications. This kit includes properly selected PLGA, PLA, and PCL polymers and stabilizer, allowing for rapid screening of optimal materials for enhanced drug loading and controlled drug release.
Leistungsmerkmale und Vorteile
- Ready-to-use polymer drug formulation screening kit for non-PEGylated nanoparticles
- Choose from either nanopreciptiation or microfluidics-based protocols
- Create specifically sized, biodegradable, PLGA, PLA, or PCL nanoparticles
- Maximize the encapsulation of hydrophobic drugs
- Four different non-PEGylated polymers are included
Angaben zur Herstellung
Comprehensive protocols for nanoparticle synthesis methods are included:
The microfluidics protocol uses NanoFabTx™ device kits (911593), which provide the microfluidics chips, fittings, and tubing required to get started with microfluidics-based synthesis (compatible microfluidics system or syringe pump required).
For more information, please refer to the protocol under the document section of this page.
- A nanoprecipitation protocol to prepare drug-encapsulated nanoparticles in standard laboratory glassware.
- A microfluidics protocol using commercial platforms or syringe pumps.
The microfluidics protocol uses NanoFabTx™ device kits (911593), which provide the microfluidics chips, fittings, and tubing required to get started with microfluidics-based synthesis (compatible microfluidics system or syringe pump required).
For more information, please refer to the protocol under the document section of this page.
Rechtliche Hinweise
NANOFABTX is a trademark of Sigma-Aldrich Co. LLC
Lagerklassenschlüssel
11 - Combustible Solids
WGK
WGK 3
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
S Freiberg et al.
International journal of pharmaceutics, 282(1-2), 1-18 (2004-09-01)
Polymer microspheres can be employed to deliver medication in a rate-controlled and sometimes targeted manner. Medication is released from a microsphere by drug leaching from the polymer or by degradation of the polymer matrix. Since the rate of drug release
Byung Kook Lee et al.
Advanced drug delivery reviews, 107, 176-191 (2016-06-06)
Poly(d,l-lactic acid) (PLA) has been widely used for various biomedical applications for its biodegradable, biocompatible, and nontoxic properties. Various methods, such as emulsion, salting out, and precipitation, have been used to make better PLA micro- and nano-particle formulations. They are
Nazila Kamaly et al.
Chemical Society reviews, 41(7), 2971-3010 (2012-03-06)
Polymeric materials have been used in a range of pharmaceutical and biotechnology products for more than 40 years. These materials have evolved from their earlier use as biodegradable products such as resorbable sutures, orthopaedic implants, macroscale and microscale drug delivery
Verónica Lassalle et al.
Macromolecular bioscience, 7(6), 767-783 (2007-06-02)
The controlled release of medicaments remains the most convenient way of drug delivery. Therefore, a wide variety of reports can be found in the open literature dealing with drug delivery systems. In particular, the use of nano- and microparticles devices
C Thomasin et al.
Journal of pharmaceutical sciences, 87(3), 269-275 (1998-04-02)
Phase separation (frequently called coacervation) of poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) is a classical method for drug microencapsulation. Here, attempts have been made to describe this process in the light of thermodynamics. Different PLA/PLGAs were dissolved in either dichloromethane or
Artikel
NanoFabTX kits enable precise drug delivery with lipid nanoparticles and liposomes for mRNA and nucleic acids.
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.